Literature DB >> 16199825

Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis.

Diana O Perkins1, Hongbin Gu, Kalina Boteva, Jeffrey A Lieberman.   

Abstract

OBJECTIVE: The duration of untreated psychosis may influence response to treatment, reflecting a potentially malleable progressive pathological process. The authors reviewed the literature on the association of duration of untreated psychosis with symptom severity at first treatment contact and with treatment outcomes and conducted a meta-analysis examining these relationships.
METHOD: English-language articles on duration of untreated psychosis published in peer-reviewed journals through July 2004 were reviewed. Studies that quantitatively assessed the duration of untreated psychosis; identified study subjects who met the criteria for nonaffective psychotic disorders at or close to first treatment; employed cross-sectional analyses of duration of untreated psychosis and of baseline symptoms, neurocognition, brain morphology, or functional measures or prospectively analyzed symptom change, response, or relapse; assessed psychopathology with clinician-rated instruments; and reported subjects' diagnoses (a total of 43 publications from 28 sites) were included in the meta-analysis.
RESULTS: Shorter duration of untreated psychosis was associated with greater response to antipsychotic treatment, as measured by severity of global psychopathology, positive symptoms, negative symptoms, and functional outcomes. At the time of treatment initiation, duration of initially untreated psychosis was associated with the severity of negative symptoms but not with the severity of positive symptoms, general psychopathology, or neurocognitive function.
CONCLUSIONS: Duration of untreated psychosis may be a potentially modifiable prognostic factor. Understanding the mechanism by which duration of untreated psychosis influences prognosis may lead to better understanding of the pathophysiology of schizophrenia and to improved treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16199825     DOI: 10.1176/appi.ajp.162.10.1785

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  287 in total

Review 1.  Treatment for Negative Symptoms in Schizophrenia: A Comprehensive Review.

Authors:  Selene R T Veerman; Peter F J Schulte; Lieuwe de Haan
Journal:  Drugs       Date:  2017-09       Impact factor: 9.546

2.  Disease prediction in the at-risk mental state for psychosis using neuroanatomical biomarkers: results from the FePsy study.

Authors:  Nikolaos Koutsouleris; Stefan Borgwardt; Eva M Meisenzahl; Ronald Bottlender; Hans-Jürgen Möller; Anita Riecher-Rössler
Journal:  Schizophr Bull       Date:  2011-11-10       Impact factor: 9.306

3.  Prodromal schizophrenia in primary care: a randomised sensitisation study.

Authors:  Andor E Simon; Sabrina Jegerlehner; Thomas Müller; Katja Cattapan-Ludewig; Peter Frey; Marcus Grossenbacher; Erich Seifritz; Daniel Umbricht
Journal:  Br J Gen Pract       Date:  2010-09       Impact factor: 5.386

Review 4.  Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment.

Authors:  Trevor Archer; Richard M Kostrzewa; Tomas Palomo; Richard J Beninger
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

Review 5.  Review of the operational definition for first-episode psychosis.

Authors:  Nicholas J K Breitborde; Vinod H Srihari; Scott W Woods
Journal:  Early Interv Psychiatry       Date:  2009-11       Impact factor: 2.732

6.  Brightening the future: supporting youth to reach their potential.

Authors:  Linda Rosenberg
Journal:  J Behav Health Serv Res       Date:  2015-04       Impact factor: 1.505

7.  First aid recommendations for psychosis: using the Delphi method to gain consensus between mental health consumers, carers, and clinicians.

Authors:  Robyn L Langlands; Anthony F Jorm; Claire M Kelly; Betty A Kitchener
Journal:  Schizophr Bull       Date:  2007-09-03       Impact factor: 9.306

8.  Family processes and duration of untreated psychosis among US Latinos.

Authors:  Mercedes Hernandez; Maria Y Hernandez; Daisy Lopez; Concepción Barrio; Diana Gamez; Steven R López
Journal:  Early Interv Psychiatry       Date:  2019-01-15       Impact factor: 2.732

9.  Youth-caregiver agreement on clinical high-risk symptoms of psychosis.

Authors:  Shana Golembo-Smith; Peter Bachman; Damla Senturk; Tyrone D Cannon; Carrie E Bearden
Journal:  J Abnorm Child Psychol       Date:  2014-05

10.  Characterization of the deficit syndrome in drug-naive schizophrenia patients: the role of spontaneous movement disorders and neurological soft signs.

Authors:  Victor Peralta; Lucía Moreno-Izco; Ana Sanchez-Torres; Elena García de Jalón; Maria S Campos; Manuel J Cuesta
Journal:  Schizophr Bull       Date:  2012-12-18       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.